Transapical aortic valve replacement versus surgical aortic valve replacement: A subgroup analyses tor at-risk populations

被引:8
|
作者
Stachon, Peter [1 ]
Kaier, Klaus [2 ]
Oettinger, Vera [1 ]
Bothe, Wolfgang [3 ]
Zehender, Manfred [1 ]
Bode, Christoph [1 ]
von zur Muehlen, Constantin [1 ]
机构
[1] Univ Freiburg, Dept Cardiol & Angiol 1, Fac Med, Heart Ctr Freiburg, Freiburg, Germany
[2] Univ Freiburg, Univ Med Ctr Freiburg, Fac Med, Inst Med Biometry & Stat, Freiburg, Germany
[3] Univ Freiburg, Fac Med, Heart Ctr Freiburg, Dept Cardiac & Vasc Surg, Freiburg, Germany
来源
关键词
TA-TAVR; SAVR; outcome; mortality; complication; TASK-FORCE; TRANSCATHETER; IMPLANTATION; STENOSIS; METAANALYSIS; MANAGEMENT; SURGERY; GERMANY; TRIAL;
D O I
10.1016/j.jtcvs.2020.02.078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: If the transfemoral access is not feasible, a transapical access or surgical aortic valve replacement (SAVR) are alternatives for patients with aortic valve stenosis. Objectives: To identify patient groups who benefit from SAVR or transapical transcatheter aortic valve replacement (TA-TAVR), we compared in-hospital outcomes of patients in a nationwide dataset. Methods: We identified 19,016 isolated SAVR and 6432 TA-TAVR performed in Germany from 2014 to 2016. We adjusted for risk factors using a covariate- and propensity-adjusted analysis. Results: Patients undergoing TA-TAVR were older, had more comorbidities, and accordingly greater estimated operative risk (logistic European System for Cardiac Operative Risk Evaluation 5.3 vs 17.0, P < .001). However, adjusted risk for in-hospital complications such as stroke, acute kidney injury, relevant bleeding, and prolonged mechanical ventilation >48 hours was lower in patients undergoing TA-TAVR (all P < .001). When we compared in-hospital mortality of all patients undergoing either TA-TAVR or SAVR, neither treatment strategy had a clear advantage (covariate-adjusted odds ratio [caOR], 1.13, P = .251; propensity-adjusted OR [paOR], 1.12, P = .309). Two patient subgroups seem to benefit more from SAVR than TA-TAVR: patients <75 years (caOR, 1.29, P = .237; paOR, 2.12, P = .001) and those with European System for Cardiac Operative Risk Evaluation 4-9 (caOR, 1.32, P = .114; paOR, 1.43, P = .041). Female patients had a tendency toward lower risk for in-hospital mortality when undergoing SAVR (caOR, 1.42, P = .030). In patients with chronic renal failure, TA-TAVR was superior (caOR, 0.56, P = .039, P = .040). Conclusions: Patients <75 years and those at low operative risk who underwent SAVR had lower in-hospital mortality than those undergoing TA-TAVR. Patients with chronic renal failure who underwent TA-TAVR had lower in hospital mortality than those that underwent SAVR.
引用
收藏
页码:1701 / +
页数:10
相关论文
共 50 条
  • [1] Commentary: Transapical aortic valve replacement versus surgical aortic valve replacement: A fundamental touchstone! Comment
    Kuhn, Elmar W.
    Liakopoulos, Oliver J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 162 (06): : 1710 - 1711
  • [2] Redo Surgical Aortic Valve Replacement versus Valve in Valve Transcatheter Aortic Valve Replacement
    Patel, Parth M.
    Chiou, Edward
    Wei, Jane W.
    Binongo, Jose N.
    Guyton, Robert A.
    Leshnower, Bradley G.
    Grubb, Kendra J.
    Chen, Edward P.
    CIRCULATION, 2020, 142
  • [3] Transapical aortic valve replacement
    Prodan-Bhalla, Natasha
    Weepers, Christy
    Brownjohn, Kim
    Pottinger, Katrien
    Polzer, Hilary
    Beaulac, Stephan
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 317C - 318C
  • [4] Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement
    Pompeu, Michel
    Van den Eynde, Jef
    Simonato, Matheus
    Pibarot, Philippe
    Clavel, Marie-Annick
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (08) : 926 - 928
  • [5] TRANSCATHETER AORTIC VALVE REPLACEMENT VERSUS SURGICAL AORTIC VALVE REPLACEMENT IN A LOW TO INTERMEDIATE RISK POPULATION
    Macon, Conrad
    Singh, Vikas
    O'Neill, Brian
    Kattan, Cesia Gallegos
    Tanawuttiwat, Tanyanan
    Lucero, Thomas
    Carrillo, Roger
    Williams, Donald B.
    O'Neill, William
    Heldman, Alan
    Martinez, Claudia
    Alfonso, Carlos
    Cohen, Mauricio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1976 - A1976
  • [6] Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosis
    Thakkar, Badal
    Patel, Aashay
    Mohamad, Bashar
    Patel, Nileshkumar J.
    Bhatt, Parth
    Bhimani, Ronak
    Patel, Achint
    Arora, Shilpkumar
    Savani, Chirag
    Solanki, Shantanu
    Sonani, Rajesh
    Patel, Samir
    Patel, Nilay
    Deshmukh, Abhishek
    Mohamad, Tamam
    Grines, Cindy
    Cleman, Michael
    Mangi, Abeel
    Forrest, John
    Badheka, Apurva O.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (05) : 955 - 962
  • [7] Valve-in-valve transcatheter aortic valve replacement versus isolated redo surgical aortic valve replacement
    Yousef, Sarah
    Serna-Gallegos, Derek
    Iyanna, Nidhi
    Kliner, Dustin
    Brown, James A.
    Toma, Catalin
    Makani, Amber
    West, David
    Wang, Yisi
    Thoma, Floyd W.
    Ahmad, Danial
    Yoon, Pyongsoo
    Chu, Danny
    Kaczorowski, David
    Bonatti, Johannes
    Sultan, Ibrahim
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (04): : 1003 - 1010
  • [8] Transcatheter and Transapical Aortic Valve Replacement
    McRae, Marion E.
    Rodger, Marnie
    Bailey, Barbara A.
    CRITICAL CARE NURSE, 2009, 29 (01) : 22 - 36
  • [9] Transcatheter Aortic Valve Replacement versus Surgical Aortic Valve Replacement: A Review of Aortic Stenosis Management
    Sattar, Yasar
    Rauf, Hiba
    Bareeqa, Syeda Beenish
    Ullah, Waqas
    Myla, Madhura
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (12)
  • [10] Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement
    Fudim, Marat
    Bloomfield, Gerald S.
    Samad, Zainab
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (08) : 605 - 606